Page last updated: 2024-08-16

pirinixic acid and myelin oligodendrocyte glycoprotein (35-55)

pirinixic acid has been researched along with myelin oligodendrocyte glycoprotein (35-55) in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Archer, DC; Cunard, R; DiCampli, D; Glass, CK; Kelly, CJ; Ricote, M; Stevenson, JL1

Other Studies

1 other study(ies) available for pirinixic acid and myelin oligodendrocyte glycoprotein (35-55)

ArticleYear
WY14,643, a PPAR alpha ligand, has profound effects on immune responses in vivo.
    Journal of immunology (Baltimore, Md. : 1950), 2002, Dec-15, Volume: 169, Issue:12

    Topics: Administration, Oral; Animals; Antibody Formation; Apoptosis; B-Lymphocyte Subsets; Cell Death; Cytokines; Glycoproteins; Growth Inhibitors; Immunosuppressive Agents; Ligands; Lymphocyte Count; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Myelin-Oligodendrocyte Glycoprotein; Peptide Fragments; Peroxisome Proliferators; Peroxisomes; Pyrimidines; Receptors, Cytoplasmic and Nuclear; Spleen; T-Lymphocyte Subsets; Transcription Factors

2002